Home Cart Sign in  
Chemical Structure| 1338934-59-0 Chemical Structure| 1338934-59-0

Structure of MKC8866
CAS No.: 1338934-59-0

Chemical Structure| 1338934-59-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MKC8866 is an inositol requiring enzyme 1 (IRE-1α) inhibitor with IC50<0.1 μM.

Synonyms: Orin1001; IRE1-IN-8866

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Gideon Ong ; Rosemund Ragetli ; Katarzyna Mnich ; Bradley W. Doble ; Wafa Kammouni ; Susan E. Logue

Abstract: The Unfolded Response (UPR) is an essential cellular process activated by the accumulation of unfolded proteins within the Endoplasmic Reticulum (ER), a condition referred to as ER stress. Three ER anchored receptors, , and ATF6 act as ER stress sensors monitoring the health of the ER. Upon detection of ER stress, , and ATF6 initiate downstream signaling pathways collectively referred to as the UPR. The overarching aim of the UPR is to restore ER homeostasis by reducing ER stress, however if that is not possible, the UPR transitions from a pro-survival to a pro-death response. While our understanding of the key signaling pathways central to the UPR is well defined, the same is not true of the subtle signaling events that help fine tune the UPR, supporting its ability to adapt to varying amplitudes or durations of ER stress. In this study, we demonstrate cross talk between the and branches of the UPR, wherein via XBP1s signaling helps to sustain expression during prolonged ER stress. Our findings suggest cross talk between UPR branches aids adaptiveness thereby helping to support the plasticity of UPR signaling responses.

Purchased from AmBeed:

Pineau, Raphael ; Le Reste, Pierre Jean ; Avril, Tony ; Jarry, Ulrich ; Chevet, Eric ; Pelizzari-Raymundo, Diana

Abstract: In cancer research, murine models play a crucial role as highly valuable preclinical tools. Here, we present a protocol to generate a murine model of glioblastoma through the direct intracranial injection of tumor cells. We describe steps for , intracranial implantation, and standard-of-care treatments. We then detail procedures for monitoring tumor growth using bioluminescent imaging.

Purchased from AmBeed:

Alternative Products

Product Details of MKC8866

CAS No. :1338934-59-0
Formula : C18H19NO7
M.W : 361.35
SMILES Code : O=CC1=C(C(C(C)=C2CC(N3CCOCC3)=O)=CC(OC)=C1O)OC2=O
Synonyms :
Orin1001; IRE1-IN-8866
MDL No. :MFCD31540824
InChI Key :IFDGMRMUJYGWQQ-UHFFFAOYSA-N
Pubchem ID :89542346

Safety of MKC8866

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RPMI 8226 cells 0.14 μM MKC8866 showed an IC50 of 0.14 μM in unstressed RPMI 8226 cells. PMC6345973
MM1 cells 0.52 μM MKC8866 strongly inhibited DTT-induced XBP1s expression in MM1 cells. PMC6345973
LNCaP cells 0.2, 0.5, 1, 5, 10 μM 24 h MKC8866 suppressed XBP1s expression in a dose-dependent manner in LNCaP cells and inhibited the expression of XBP1s target genes BiP and P58IPK, while phospho-IRE1α or total IRE1α levels were not affected. PMC6345973
Myc-CaP cells 10 µM 12 h To evaluate the effect of MKC8866 on apoptosis in Myc-CaP cells PMC11480464
U251 cells 30 µM 72 h MKC8866 significantly reduced the viability of U251 cells and inhibited IRE1-1 α RNase activity, leading to a decrease in XBP-1s protein levels. PMC7690447
U87 cells 30 µM 72 h MKC8866 significantly reduced the viability of U87 cells and inhibited IRE1-1 α RNase activity, leading to a decrease in XBP-1s protein levels. PMC7690447

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Prostate cancer xenograft model Oral 300 mg/kg Daily MKC8866 significantly inhibited xenografted tumor growth in all tested prostate cancer cell lines and reduced XBP1s expression, while decreasing PCNA expression and increasing cleaved Caspase-3 levels, indicating that MKC8866 treatment resulted in decreased proliferation and increased apoptosis. PMC6345973
Mice Myc-CaP tumor model Oral 300 mg/kg Every other day or daily, until the end of the experiment To evaluate the inhibitory effect of MKC8866 on Myc-CaP tumor growth PMC11480464

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.84mL

2.77mL

1.38mL

27.67mL

5.53mL

2.77mL

References

 

Historical Records

Categories